![Roy Baynes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy Baynes
Directeur Technique/Scientifique/R&D chez
EIKON THERAPEUTICS, INC.
Fortune : 6 M $ au 31/05/2026
Profil
Dr. Roy D.
Baynes is an Independent Director at Nurix Therapeutics, Inc., an Independent Non-Executive Director at ADCendo ApS, an Independent Director at Aardvark Therapeutics, Inc., a Chief Medical Officer & Executive Vice President at Eikon Therapeutics, Inc., an Independent Director at Natera, Inc., an Independent Director at Travere Therapeutics, Inc., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc. and a Member at American Society of Hematology.
He is on the Board of Directors at Nurix Therapeutics, Inc., ADCendo ApS, Aardvark Therapeutics, Inc., CatalYm GmbH, Natera, Inc. and Travere Therapeutics, Inc. Dr. Baynes was previously employed as an Independent Director by Atara Biotherapeutics, Inc., a Chief Medical Officer by Merck & Co., Inc., a Chief Medical Officer by Merck Research Laboratories Massachusetts LLC, a SVP-Oncology, Inflammation & Respiratory by Gilead Sciences, Inc., a VP-Global Development & Head-Hematology Oncology by Amgen, Inc., and a Professor by Barbara Ann Karmanos Cancer Institute.
He received his graduate degree from the University of the Witwatersrand and a doctorate degree from the University of the Witwatersrand.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NATERA, INC. 0,01 % | 24/04/2026 | 18 429 ( 0,01 % ) | 4 M $ | 31/05/2026 |
| 19/05/2026 | 41 500 ( 0,04 % ) | 2 M $ | 31/05/2026 | |
| 15/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 02/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Roy Baynes
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2016 |
| NATERA, INC. | Directeur/Membre du Conseil | 25/07/2018 |
| EIKON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2022 |
| AARDVARK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2024 |
| NURIX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/03/2025 |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
CatalYm GmbH
 CatalYm GmbH Pharmaceuticals: MajorHealth Technology Specializes in catalyzing immunotherapy | Directeur/Membre du Conseil | 01/01/2024 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Roy Baynes
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Roy Baynes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Natera, Inc.
 Natera, Inc. BiotechnologyHealth Technology Engages in development and commercialization of molecular testing and technology services in the fields of women’s, oncology and organ health | Health Technology |
Barbara Ann Karmanos Cancer Institute
 Barbara Ann Karmanos Cancer Institute Hospital/Nursing ManagementHealth Services Provides health care services for cancer patients | Health Services |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
CatalYm GmbH
CatalYm GmbH Pharmaceuticals: MajorHealth Technology Specializes in catalyzing immunotherapy | Health Technology |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Health Technology |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical and drug discovery company | Health Technology |
